CN Patent

CN106715421A — 用于治疗hiv相关病症的方法和组合物

Assigned to CHDI Foundation Inc · Expires 2017-05-24 · 9y expired

What this patent protects

本申请提供了包含犬尿氨酸‑3‑单加氧酶抑制剂和用于治疗HIV相关病症的抗病毒剂的某些辅助疗法。这些病症包括AIDS痴呆综合征、AIDS诱发的脑病、HIV相关的神经认知障碍、无症状的神经认知缺损、轻微的神经认知障碍、轻微的认知运动障碍、空泡性脊髓病、周围神经病变和多肌炎。本申请还提供了包含犬尿氨酸‑3‑单加氧酶抑制剂和抗病毒剂的药物组合物。

USPTO Abstract

本申请提供了包含犬尿氨酸‑3‑单加氧酶抑制剂和用于治疗HIV相关病症的抗病毒剂的某些辅助疗法。这些病症包括AIDS痴呆综合征、AIDS诱发的脑病、HIV相关的神经认知障碍、无症状的神经认知缺损、轻微的神经认知障碍、轻微的认知运动障碍、空泡性脊髓病、周围神经病变和多肌炎。本申请还提供了包含犬尿氨酸‑3‑单加氧酶抑制剂和抗病毒剂的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN106715421A
Jurisdiction
CN
Classification
—
Expires
2017-05-24
Drug substance claim
No
Drug product claim
No
Assignee
CHDI Foundation Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.